Stay updated on Gene Transfer for SMA Type 1 Clinical Trial
Sign up to get notified when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.

Latest updates to the Gene Transfer for SMA Type 1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to reflect a new version, v2.15.2, while the previous version, v2.15.0, and the mention of the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital have been removed.SummaryDifference0.5%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a clinical trial for AVXS-101 in treating Spinal Muscular Atrophy Type 1, while retaining some identifiers and study locations.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Gene Transfer for SMA Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.